UChicagoTech

Suzanne Conzen, MD, is expediting the bench-to-bedside process with a rare investigator-initiated Phase I clinical trial for a novel approach to breast cancer therapy.
Read full story »

Richard P. Kraig, PhD, MD, and his team are developing a new treatment that promises to halt migraine triggers.
Read full story »

Professor Ralph Weichselbaum, MD, and colleagues are working to validate a new test to predict individual benefit from radiation or chemotherapy, an effort funded by UChicago.
Read full story »

The University awarded investigator Michael Thirman, MD, $50,000 to continue his research on a promising drug candidate for treating a devastating form of leukemia.
Read full story »

Licensees of Dmitri Talapin's "electronic glue" and nanocrystal technology are developing a number of killer apps
Read full story »

Cardiologist Michael Davidson, MD, has co-founded two companies and is currently developing a promising therapy that may help lower cholesterol levels.
Read full story »

Co-investigators Susan Cohn and Alexandre Chlenski received one of two pilot innovation fund grants to explore the broader use of a drug candidate they've developed for treating cancer.
Read full story »

Chemistry professor Ka Yee Lee and postdoctoral scholar Niels Holten-Andersen and team have invented a new synthetic mussel-inspired material that exhibits both strength and reversibility.
Read full story »

The next stage for the commercially successful computer-aided technology for detecting breast and lung cancer developed by Professor Maryellen Giger and colleagues includes detection and diagnosis of colon and prostate cancer and cardiovascular disease as well as virtual biopsies.
Read full story »

Professor Julian Solway, MD, conducts translational research that seeks to develop novel treatments for asthma.
Read full story »

Investigator Heinrich Jaeger and colleagues are developing a new universal gripper technology for licensing.
Read full story »

University Provost Thomas Rosenbaum and colleagues have developed a new technology that could improve the speed, stability, energy efficiency and storage capacity of next-generation computer hard drives, while decreasing their size.
Read full story »

A frequent discloser to UChicagoTech, Ralph Weichselbaum, MD, The D.K. Ludwig Professor and Chairman of the Department of Radiation and Cellular Oncology, has generated a sizeable patent portfolio.
Read full story »

University investigator Godfrey Getz, MD, is developing a new approach for treating atherosclerosis with the potential to reverse coronary heart disease.
Read full story »

University researcher Laurens Mets has developed an efficient method for large-scale storage of solar and wind power.
Read full story »

Distinguished investigator, innovator, consultant, and author Olaf Schneewind denies being a renaissance man.
Read his story »

In his role as CEO of Midway Pharmaceuticals, Rifat Pamukcu draws on a wealth of experience and connections gained through the University of Chicago.
Read full story »

UChicagoTech executive-in-residence Richard Ganz plays a vital role helping connect research faculty with clinical resources and expertise, both inside and outside the University.
Read full story »

Executive-in-Residence Joseph Feldman is applying his business development expertise and contacts to further UChicago technology commercialization.
Read full story »

Experienced surgeon and entrepreneur, Steven Gould, MD, is helping to advance UChicago innovation as well as biotech and life sciences for the whole region as an entrepreneur-in-residence at UChicagoTech.
Read full story »

UChicagoTech executive-in-residence Nancy Harvey lends business expertise to faculty and staff looking to commercialize innovations.
Read full story »

Successful entrepreneur and alumnus John Van Dyke, MBA 1969, offers advice and real world experience to UChicagoTech
Read full story »

Ellen Rudnick, MBA ’73, Executive Director of the Polsky Center for Entrepreneurship at the Booth School of Business, works to further University innovation by fostering collaboration both inside and outside of the university.
Read full story »

Charles Polsky, MD ’96, head of biotechnology investment at William Harris Investors, lends his experience and expertise to UChicagoTech with advice on drug development and investment strategies.
Read full story »

A distinguished panel of UChicago alumni discuss the effects of a tough economy on life sciences innovation at the inaugural event of the UChicago Mid-Atlantic Bio-Life Sciences Alumni Group in Manhattan.
Read full story »

Karen Kerr, PhD ’95, U.S. Head of Business Development at Intellectual Ventures (IV), hopes to spur investment in UChicago innovation by building a mutually beneficial partnership. Read story »

Medical expert, entrepreneur, venture capitalist, Martin E. Sanders, MD, ’79, provides invaluable advice and perspective to University innovators to help bring new therapeutics for diseases to market.
Read full story »

Alumnus Doug Given, Investment Partner at Bay City Capital, and advisor to UChicagoTech, helps to bridge gaps between the University and the business world.
Read full story »

Norm Winarsky, SB’69, SM’70, and PhD’74, lends his experience and expertise to UChicagoTech.
Read his story »

UChicago licensee Electrochaea uses electricity generated by the sun or wind to convert water and carbon dioxide into methane, the chief ingredient of natural gas.
Read full story »

University of Chicago MBA student and entrepreneur Brian Luerssen co-founded Quantitative Insights based on Professor Maryellen Giger's computer-aided breast cancer diagnosis technology.
Read full story »

Three UChicago physicians (left to right) Adam Cifu, MD, Scott Stern, MD, and Diane Altkorn, MD, developed the content for a new Web app diagnosis tool licensed by startup Agile Diagnosis.
Read full story »

Last year, UChicagoTech invested $30,000 in start-up Reflexion, prompting $450,000 from additional investors.
Read full story »

UChicago licensee NephRx is moving swiftly to bring to market therapeutics for patients with kidney transplants and mucositis.
Read full story »

Stephen Kent, UChicago Professor of Chemistry, and partners founded start-up Reflexion in 2009 with the goal of creating more effective protein therapeutics.
Read full story »

Investigator Ben Glick and colleagues have engineered red fluorescent proteins used to visualize specific cells in living organisms in a variety of research areas. The technology is licensed by UChicago to Clontech Laboratories.
Read full story »

Timothy Knowles, PhD, John Dewey Director, Urban Education Institute, is in discussions with McGraw-Hill about commercializing UEI tools that help improve teaching and learning.
Read full story »

Lance Stewart, CEO of Emerald BioSystems and Emerald BioStructures, licenses UChicago technology to crystallize proteins for basic research and drug discovery.
Read full story »

University startup, Arryx, was recently acquired by Haemonetics for $32 million to bring its innovative holographic optical trapping technology to the immunodiagnostics market.
Read full story »

Company is developing cells for portable electronic devices that will incorporate technology invented by the University of Chicago.
Read full story »

Chromatin, a company developed by UChicagoTech, collaborates with companies to bring agricultural technologies to the marketplace.
Read the full story »

UChicagoTech startup Midway Pharmaceuticals is ready to take its novel method for disarming bacteria in the gastrointestinal tract to the next level.
Read their story »

University startup SmartSignal helps companies save money and operate more efficiently and safely, without interruption.
Read SmartSignal's story »

The Innovation Workshop at Chicago Booth featured experts on how to use the Small Business Innovation Research program creatively to launch start-ups at universities.
Read full story »

John Flavin serves as the executive director of Chicago Innovation Mentors, a multi-institution initiative that cultivates university-based biomedical and healthcare commercialization.
Read full story »

Chicago area scientists, inventors and technology transfer staffs gather for inaugural Chicago Innovation Spotlight program.
Read full story »

The Chicago Innovation Pipeline highlights licensable technologies from Chicago-area research institutions in one user-friendly database.
Read full story »

The fourth annual Midwest Energy Forum attracted more than 300 attendees including Chicago Mayor-elect Rahm Emanuel and Clean Energy Trust board member Nick Pritzker.
Read full story »

The inaugural event of the new Chicago Innovators Mentors program matched experienced entrepreneurs, executives, and domain experts with innovating faculty from multiple institutions.
Read full story »

Larry Keeley, President and Co-founder, Doblin Inc., talks about the science and discipline of innovation at the November 17, 2010 ARCH Venture Partners Innovation Workshop.
Read full story »

Innovation Workshop speaker David Mack, PhD '92, Director of Alta Partners, encourages researchers who think their ideas or technologies have commercial potential to go for it.
Read full story »

The University of Chicago was a major participant in 2010 BIO International Convention held at Chicago’s McCormick Place May 3-6, 2010. UChicagoTech staff and University faculty were on hand to discuss regional biotech breakthroughs and what’s in store for the future.
Read full story »

At the April 15 Innovation Workshop, former head of innovation and technology at IBM Nick Donofrio explains how IBM overcame “near death” in the early nineties and transformed itself into a $100 billion technology giant.
Read full story »

Professor Carole Ober presents her research to industry experts during her biomarker session with industry experts.
Read full story »

In celebration of the close links between innovation and art, entrepreneurship and economic empowerment, UChicagoTech teamed up with local non-profit Little Black Pearl on a very special art opening and exhibit.
Read full story »

UChicagoTech’s translational programs help investigators like Patrick Singleton assess the commercial potential of their discoveries. Read the full story »

The Polsky Center for Entrepreneurship and UChicagoTech launch a new monthly Innovation Workshop series. Read the full story »